Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6111]

DNA methylation makes cancer cells more vulnerable to immune response

DNA methylation makes cancer cells more vulnerable to immune response

CHMP approves niraparib and abiraterone acetate plus prednisone or prednisolone for the treatment of adult patients with BRCA1/2 gene-mutated mCRPC

CHMP approves niraparib and abiraterone acetate plus prednisone or prednisolone for the treatment of adult...

Severe herpesvirus infection beats adult T-cell leukaemia/lymphoma

Severe herpesvirus infection beats adult T-cell leukaemia/lymphoma

NICE recommends first immunotherapy- chemotherapy combination for neoadjuvant treatment of resectable NSCLC

NICE recommends first immunotherapy- chemotherapy combination for neoadjuvant treatment of resectable NSCLC

ASCO GU 2023: Polymerase inhibitor significantly improves progression-free survival for metastatic prostate cancer

ASCO GU 2023: Polymerase inhibitor significantly improves progression-free survival for metastatic prostate cancer

Ponatinib more effective than imatinib for newly diagnosed Ph+ALL leukaemia patients

Ponatinib more effective than imatinib for newly diagnosed Ph+ALL leukaemia patients

ASCO GU 2023: Update on bladder-sparing treatment trial: RETAIN BLADDER

ASCO GU 2023: Update on bladder-sparing treatment trial: RETAIN BLADDER

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

The next step in the preventive breast cancer vaccine study

The next step in the preventive breast cancer vaccine study

Use of methotrexate is associated with an increased risk of skin cancer

Use of methotrexate is associated with an increased risk of skin cancer

More from ecancer